Caricamento...
Converting biology into clinical benefit: lessons learned from BRAF inhibitors
The identification and pharmacological targeting of activating BRAF mutations in melanoma has led to significant improvements in patient outcomes. This perspective paper illustrates the lessons learned from the study of BRAF mutations and the development of BRAF inhibitors. The relevance of these le...
Salvato in:
| Pubblicato in: | Melanoma Manag |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Future Medicine Ltd
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4649930/ https://ncbi.nlm.nih.gov/pubmed/26594316 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt.15.18 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|